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Pseudocyst formation is a recognised complication of acute pancre-
atitis. Rarely, they result in pseudoaneurysm formation of neighbour-
ing vessels which can be rapidly fatal if rupture occurs. We report
a case of a pseudoaneurysm of the descending thoracic aorta in
a mediastinal pancreatic pseudocyst and its management with
endovascular prosthetic stent graft. This is the first reported case of
a thoracicaorticpseudoaneurysmcomplicatinga thoracicpseudocyst.
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Introduction: The treatment options for an infected fenestrated
endovascular aneurysm repair (FEVAR) are limited.
Report: A patient with a bi-renal FEVAR developed a type 1a and
type 3 endoleak, with destruction of the neck of the aneurysm,
likely due to infection. In a tapered thoracic aortic stent, “home-
made” fenestrations were created for the renal arteries and supe-
rior mesenteric artery. Successful coverage of the infected aorta
excluded the endoleaks. Life-long antibiotics were commenced.* Full articles available online at www.ejvesextra.com
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doi:10.1016/j.ejvs.2011.06.049Discussion: There was a risk of imminent rupture, thus ruling out
waiting for a custom-made FEVAR. This technique facilitated emer-
gent treatment, and obviated the need for open surgery.
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Introduction: Hemodialysis Reliable Outflow (HeRO) (Hemosphere
Inc, Minneapolis, MN, USA) vascular access device is a new long-
term subcutaneous access designed for patients who have ex-
hausted traditional peripheral access sites.
Report: We describe the use of the HeRO device not to create new
access but to resolve symptoms of venous hypertension and salvage
still functional arteriovenous fistula (AVF) in a patient refractory to
endovascular treatment of recurrent central venous occlusive
disease (CVOD).
Conclusion: This report reinforces the experience of other authors
that the HeRO device is an effective means to salvage an AV access
and relieve symptoms of venous hypertension.
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